News | Digital Radiography (DR) | October 04, 2017

Technology will now be featured on XPERT 80 Specimen X-ray System to visualize larger specimens

Kubtec Announces Expansion of 3-D Tomosynthesis Technology

October 4, 2017 — Kubtec announced at the annual conference of the American Association of Pathology Assistants (AAPA) that they are expanding their proprietary use of 3-D tomosynthesis by bringing it to the XPERT 80 Specimen X-ray System. Kubtec introduced 3-D imaging for clinical specimens with the Mozart System, the first specimen X-ray system to use 3-D tomosynthesis, according to the company. 
 
This technology has now been scaled up to enable healthcare professionals to visualize larger specimens such as full mastectomies and even the longest of bone specimens — all in 3-D.
 
The digital X-ray company plans to have this technology incorporated into the XPERT 80 System by the end of 2017.

For more information: www.kubtec.com


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Radiology Business

March 12, 2026 — DelveInsight's has released its latest Diagnostic Imaging Equipment Market Insights report. The in ...

Time March 13, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | HIMSS

March 3, 2026 — MedDream will present its cloud-native, AI-ready universal DICOM viewer in the Amazon Web Services (AWS) ...

Time March 03, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
Subscribe Now